While nearly 18% of U.S. adults have taken a GLP 1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, The New York Times spotlighted MEDVi. The FDA had already warned the self proclaimed 'fastest growing company in history.' Drug Discovery and Development Semaglutide GLP 1 for Medical Weight Loss in Wappingers Falls Can Semaglutide Cause irregular Periods